Here are six observations:
1. The market will likely reach $12.56 billion by 2027.
2. The great number of spinal cord injuries and growing awareness of treatment options will spur market growth.
3. The costliness of spinal fusions and growth of alternative surgery methods, among other factors, will hinder market growth.
4. The interbody cages segment will experience significant growth between 2017 and 2027.
5. Based on procedure, the interbody fusion sector will continue to lead the market through 2027.
6. North America will grow at a 4.7 percent CAGR through 2027 and the Asia-Pacific (excluding Japan) region will register an 8.9 percent CAGR.
More articles on devices:
Hospital for Special Surgery partners with pSivida to develop drug releasing implant: 5 things to know
DePuy Synthes to provide financing options for orthopedic surgery table: 4 key notes
NuVasive acquires SafePassage to expand neuromonitoring business: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.